triphenyltetrazolium has been researched along with agmatine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SW; Giffard, RG; Kim, JH; Lee, JE; Park, KA; Yenari, MA | 1 |
1 other study(ies) available for triphenyltetrazolium and agmatine
Article | Year |
---|---|
Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury.
Topics: Agmatine; Analysis of Variance; Animals; Animals, Newborn; Blotting, Western; Brain Infarction; Cell Count; Cell Hypoxia; Cells, Cultured; Disease Models, Animal; Functional Laterality; Gene Expression Regulation; Glucose; Hypoxia; Immunohistochemistry; Ischemic Attack, Transient; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred ICR; Neurons; Neuroprotective Agents; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitrites; Tetrazolium Salts; Time Factors | 2004 |